PRESS RELEASE published on 10/08/2024 at 14:30, 30 days 21 hours ago Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial Jaguar Health, Inc. announced a late-breaking abstract on diarrhea management from a placebo group study in breast cancer patients. Further FDA discussions planned Jaguar Health Diarrhea Management Breast Cancer Patients FDA Discussions Placebo Group Study
BRIEF published on 10/01/2024 at 14:35, 1 month 6 days ago Jaguar Health rapporte une amélioration statistiquement significative chez les patientes atteintes d'un cancer du sein dans son essai de phase 3 OnTarget pour son médicament de soins de soutien contre le cancer Crofelemer Crofelemer Essai Clinique Santé Jaguar Cancer Du Sein Essai D'OnTarget
BRIEF published on 10/01/2024 at 14:35, 1 month 6 days ago Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer Crofelemer Jaguar Health Clinical Trial OnTarget Trial Breast Cancer
PRESS RELEASE published on 10/01/2024 at 14:30, 1 month 6 days ago Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer Jaguar Health, Inc. announces positive results for crofelemer in breast cancer patients from OnTarget trial, to be presented at an oncology conference with potential for future submissions. Crofelemer also shows promise in IBS-D patients Crofelemer Jaguar Health Breast Cancer IBS-D Oncology Conference
BRIEF published on 09/26/2024 at 16:05, 1 month 11 days ago Un membre du conseil consultatif de Jaguar Health fera une présentation au symposium ASCO sur la qualité des soins Santé Jaguar Stacey Tinianov Symposium De L'ASCO Enquête Sur La Qualité De Vie Liée Au Cancer Soins De Soutien
BRIEF published on 09/26/2024 at 16:05, 1 month 11 days ago Jaguar Health Advisory Board Member to Present at ASCO Quality Care Symposium Jaguar Health ASCO Symposium Cancer QoL Survey Supportive Care Stacey Tinianov
PRESS RELEASE published on 09/26/2024 at 16:00, 1 month 11 days ago Jaguar Health Scientific Advisory Board Member to Share Poster Presentation at American Society of Clinical Oncology (ASCO) Quality Care Symposium About the Methodologies Involved in Designing an Advocate-Led Quality of Life Survey for Cancer Patients and Jaguar Health, Inc. focuses on cancer supportive care & quality of life for patients. ASCO presentation on methodologies for 'More Than a Diagnosis' survey sponsored by Napo Pharmaceuticals Napo Pharmaceuticals Quality Of Life Jaguar Health Inc. Cancer Supportive Care ASCO Presentation
BRIEF published on 09/25/2024 at 14:35, 1 month 12 days ago Jaguar Health participera à la conférence des investisseurs de Lytham Partners à l'automne 2024 Webcast Conférence Des Investisseurs Santé Jaguar Napo Pharmaceutique Médicaments Gastro-intestinaux
BRIEF published on 09/25/2024 at 14:35, 1 month 12 days ago Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference Napo Pharmaceuticals Investor Conference Webcast Jaguar Health Gastrointestinal Medicines
PRESS RELEASE published on 09/25/2024 at 14:30, 1 month 12 days ago Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 Jaguar Health's CEO Lisa Conte to participate in webcasted presentation and one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference Jaguar Health Lisa Conte Lytham Partners Investor Meetings Webcasted Presentation
Published on 11/08/2024 at 10:00, 1 hour 58 minutes ago BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 2 hours 58 minutes ago Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 4 hours 58 minutes ago Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 8 hours 58 minutes ago Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 01:25, 10 hours 33 minutes ago PetroFrontier Corp. Announces Execution of Definitive Agreements for $15.1 Million Funding Arrangement
Published on 11/08/2024 at 11:30, 28 minutes ago Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 46 minutes ago Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 48 minutes ago Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure
Published on 11/08/2024 at 11:06, 52 minutes ago Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 11/08/2024 at 11:00, 58 minutes ago BluSky Carbon CEO Presents a Case for ClimateTech Optimism
Published on 11/08/2024 at 08:00, 3 hours 58 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 16 hours 58 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 16 hours 58 minutes ago ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 58 minutes ago ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 58 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL